BRIEF published on 04/15/2025 at 09:30, 1 year ago Avis de brevet américain concernant l'innovation de More Impact AG Innovation Médicale Brevet Américain Plus D'impact AG Technologie BG Braingate Extraction De CBD
BRIEF published on 04/15/2025 at 09:05, 1 year ago LAIQON AG: Positive Growth and Financial Outlook for FY'25 Investment Recommendation Assets Under Management Financial Growth LAIQON AG Cost Management
BRIEF published on 04/15/2025 at 09:05, 1 year ago LAIQON AG : Croissance positive et perspectives financières pour l'exercice 2025 Croissance Financière LAIQON AG Actifs Sous Gestion Gestion Des Coûts Recommandation D'investissement
BRIEF published on 04/15/2025 at 09:05, 1 year ago FRIWO Achieves 2024 Targets, Anticipates Growth in 2025 Revenue Growth 2024 Targets E-mobility Strategic Realignment FRIWO
BRIEF published on 04/15/2025 at 09:05, 1 year ago FRIWO atteint ses objectifs pour 2024 et anticipe une croissance en 2025 Croissance Des Revenus Mobilité Électrique Réalignement Stratégique FRIWO Objectifs 2024
BRIEF published on 04/15/2025 at 09:05, 1 year ago Exasol AG Extends CEO Jörg Tewes' Contract Early Exasol AG Contract Extension Profitable Growth Leadership Strategy Jörg Tewes
BRIEF published on 04/15/2025 at 09:05, 1 year ago Exasol AG prolonge le contrat de son PDG Jörg Tewes par anticipation Exasol AG Croissance Rentable Stratégie De Leadership Prolongation De Contrat Jörg Tewes
BRIEF published on 04/15/2025 at 09:05, 1 year ago Blue Elephant Energy Acquires Majority Stake in Solar215 Acquisition Renewable Energy Battery Storage Blue Elephant Energy Germany Energy Market
BRIEF published on 04/15/2025 at 09:05, 1 year ago Blue Elephant Energy acquiert une participation majoritaire dans Solar215 Acquisition Énergie Renouvelable Stockage De La Batterie Énergie De L'éléphant Bleu Marché De L'énergie Allemand
BRIEF published on 04/15/2025 at 09:05, 1 year ago Cyprumed Partners with MSD on Oral Peptide Therapeutics Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
Published on 04/25/2026 at 03:10, 10 hours 38 minutes ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 15 hours 43 minutes ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:05, 15 hours 43 minutes ago Critical Elements Pleure la perte de son administrateur Marc Simpson
Published on 04/24/2026 at 22:00, 15 hours 48 minutes ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 22 hours 48 minutes ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 22:43, 15 hours 4 minutes ago EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 15 hours 43 minutes ago Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 18:30, 19 hours 18 minutes ago EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Published on 04/24/2026 at 18:12, 19 hours 35 minutes ago EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting
Published on 04/24/2026 at 18:07, 19 hours 40 minutes ago DEAG sets new records for revenue and earnings in financial year 2025 – excellently positioned for long-term growth
Published on 04/25/2026 at 07:00, 6 hours 48 minutes ago DLSI - Chiffre d'affaires 1er trimestre 2026
Published on 04/24/2026 at 18:48, 18 hours 59 minutes ago Laboratoires Euromedis - Communiqué résultat 2025
Published on 04/24/2026 at 18:00, 19 hours 48 minutes ago SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Published on 04/24/2026 at 17:45, 20 hours 3 minutes ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
